黄素作为化学预防剂诱导细胞死亡:机制和治疗潜力
Mateen Nawaz1, Arooj Nawaz2, Muhammad Nadeem Khan3
1Department of Pharmacology, Shantou University Medical College, Shantou, China.
Phytotherapy research : PTR
|August 20, 2025
概括
通过启动细胞死亡 (PCD) 途径可以预防癌症. 了解这些机制可以带来新的癌症疗法.
科学领域:
- 生物化学
- 分子生物学
- 药理学
背景情况:
- 黄类药物具有抗癌的化学预防性.
- 它们的机制包括抗氧化作用,增殖限制,血管生成抑制和免疫调节.
- 黄类药物激活各种编程细胞死亡 (PCD) 途径,在疾病治疗中至关重要.
研究的目的:
- 提供PCD的全面概述.
- 详细说明黄对启动多种PCD途径的影响.
- 在癌症预防和PCD途径阐明中探索黄类机制.
主要方法:
- 编程细胞死亡的文献审查.
- 对细胞死亡途径的黄类相互作用的分析.
- 检查PCD向药物的临床前和临床研究.
主要成果:
- 黄类药物在癌症化学预防方面具有显著的潜力.
- 它们激活多个PCD路径, 提供治疗策略.
- 了解这些途径有助于开发新的癌症治疗方法.
结论:
- 通过PCD诱导进行癌症治疗的有希望的药物.
- 对黄类药物与PCD相互作用的进一步研究可以克服耐药性.
- 这种知识可以指导癌症新疗法的开发.
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K


